Aridis Pharmaceuticals Valuation

Aridis Pharmaceuticals Asset Utilization

One of the ways to look at asset utilization of Aridis is to check how much profit was generated for every dollar of assets it reports. Aridis Pharmaceuticals shows a negative utilization of assets of -1.08 percent, losing $0.0108 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Aridis Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.

Aridis Pharmaceuticals Ownership Allocation

Aridis Pharmaceuticals holds a total of 36.21 Million outstanding shares. Aridis Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Aridis Pharmaceuticals Profitability Analysis

Net Loss for the year was (30.37 M) with loss before overhead, payroll, taxes, and interest of (22.61 M).

Investing in growth stocks can be very risky. If the company such as Aridis Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

If you are still planning to invest in Aridis Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aridis Pharmaceuticals' history and understand the potential risks before investing.